Monitoring not the answer to cryptosporidium in water

Lancet

Volumn 354, Issue 9183, 1999, Pages 967-969

  Fairley, Christopher K ^a   Sinclair, Martha I ^a   Rizak, Samantha ^a  

^a Department of Applied Chemistry   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DRINKING WATER; SURFACE WATER;

AUSTRALIA; COST; CRYPTOSPORIDIUM; ENVIRONMENTAL MONITORING; ENVIRONMENTAL PROTECTION; LAW; NOTE; PRIORITY JOURNAL; UNITED KINGDOM; WATER CONTAMINATION; WATER TREATMENT;

CRYPTOSPORIDIUM;

EID: 0033581440     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)90065-X     Document Type: Note

References (15)

1. McClellan P. Sydney Water Inquiry: final report. Sydney: Sydney Water Inquiry Secretariat, 1998.
2. The Water Supply (water quality) (amendment) regulations, 1999. London: Stationery Office, 1999.
3. O'Donoghue PJ. Cryptosporidium and cryptosporidiosis in man and animals. Int J Parasitol 1995; 25: 139-95.
4. Vesey G, Ashbolt N, Fricker E, Veal DA, Dorsch M. Fluorescent labelling of viable Cryptosporidium parvum oocysts in water samples. In: International Symposium on Waterborne Cryptosporidium - author's abstracts; March 2-5, 1997, Newport Beach, California, 1997.
5. Chappell CL. Cryptosporidium parvum volunteer studies: infectivity, illness and immunity. In: Cryptosporidium in Water 98, a consensus Conference; Oct 5, 1998, Melbourne, Australia, 1998: 11-12.
6. United States Environmental Protection Agency. National primary drinking water regulations: interim enhanced surface water treatment; final rule: 1998: [84 screens]. Available from URL: http://www.epa.gov/ogwdw000/mdbp/ieswtrfr.html (accessed on Sept 14, 1999).
7. Federal Provincial Subcommittee on Drinking Water. Protozoa in drinking water: document for public comment. Canada: Health Canada, 1997.
8. Australian Drinking Water Guidelines: National Health and Medical Research Council/Agricultural and Resource Management Council of Australia and New Zealand, 1996.
9. Department of the Environment, Transport and the Regions. Public health and drinking water: preventing cryptosporidium getting into public drinking water supplies. Consultation Paper. London: DETR, 1998.
10. van Ineveld BM, van Oortmarssen GJ, de Koning HJ, Boer R, van der Maas PJ. How cost-effective is breast cancer screening in different EC countries? Eur J Cancer 1993; 29A: 1663-68.
11. Mark DB, Hlatky MA, Califf RM, et al. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infection. N Engl J Med 1995; 332: 1418-24.
12. Public Health Laboratory Service (PHLS). Facts and figures: Cryptosporidium. 1999: [1 screen]. Available from URL http://www.phls.co.uk/facts/UKdata/cryptuk2.htm (accessed onSept 14, 1999).
13. Wheeler JG, Sethi D, Cowden JM, et al. Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. BMJ 1991; 318: 1046-50.
14. Bouchier I. Cryptosporidium in water supplies. Third report of the group of experts to Department of the Environment, Transport, and the Regions and the Department of Health. London: Department of the Environment, Transport, and the Regions and the Department of Health; 1998.
15. Sinclair MI, Fairley CK, Hellard ME. Protozoa in drinking water: is legislation the best answer? Med J Aust 1998; 169: 296-97.